Humoral response following SARS-CoV-2 vaccination: not all immunosuppressants are created equal [0.03%]
不同的免疫抑制剂对新冠病毒疫苗接种者的体液反应影响不同
Caoilfhionn M Connolly,Julie J Paik
Caoilfhionn M Connolly
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study [0.03%]
免疫抑制剂治疗的自身免疫性炎症性疾病患者接种两剂和三剂新型冠状病毒疫苗后的体液反应：队列研究
Luuk Wieske,Koos P J van Dam,Maurice Steenhuis et al.
Luuk Wieske et al.
Background: Disease-specific studies have reported impaired humoral responses after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders treated with specific immunosuppressants. Disease-overarch...
Maximilian F Konig,Katarzyna M Grzes,Philip C Robinson et al.
Maximilian F Konig et al.
The STAR care pathway for patients with pain at 3 months after total knee replacement: a multicentre, pragmatic, randomised, controlled trial [0.03%]
膝关节置换术后3个月疼痛患者的STAR关爱途径：一项多中心实用随机对照试验
Vikki Wylde,Wendy Bertram,Emily Sanderson et al.
Vikki Wylde et al.
Background: Approximately 20% of people experience chronic pain after total knee replacement, but effective treatments are not available. We aimed to evaluate the clinical effectiveness and cost-effectiveness of a new car...
Severe COVID-19 as a virus-independent immunothrombotic process - Authors' reply [0.03%]
关于严重COVID-19是一种与病毒无关的免疫性血栓形成过程的作者回信
Dennis McGonagle,Abdulla Watad,Charles Bridgewood
Dennis McGonagle
Severe COVID-19 as a virus-independent immunothrombotic process [0.03%]
新冠病毒引起的重症肺炎是一种独立于病毒的免疫性血栓形成过程
Robin Cherian,Moon Ley Tung,Bharatendu Chandra
Robin Cherian
The Editors Of The Lancet Rheumatology
The Editors Of The Lancet Rheumatology
Battling burnout [0.03%]
克服职业倦怠感
The Lancet Rheumatology
The Lancet Rheumatology
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases [0.03%]
自身免疫性炎症性风湿病患者中新冠肺炎疫苗接种接受度的变化趋势分析
Laura Boekel,Femke Hooijberg,Yaëlle R Besten et al.
Laura Boekel et al.
COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey [0.03%]
关于新冠疫苗的认知与使用情况：来自新冠肺炎全球风湿病联盟疫苗调查的结果
Michael Putman,Kevin Kennedy,Emily Sirotich et al.
Michael Putman et al.